Anita Bane

3.5k total citations
41 papers, 1.2k citations indexed

About

Anita Bane is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Anita Bane has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 17 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Anita Bane's work include Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (11 papers) and Cancer Cells and Metastasis (6 papers). Anita Bane is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (11 papers) and Cancer Cells and Metastasis (6 papers). Anita Bane collaborates with scholars based in Canada, United States and Ireland. Anita Bane's co-authors include Frances P. O’Malley, Irene L. Andrulis, John A. Hassell, Robin Hallett, Anna Dvorkin‐Gheva, Gregory R. Pond, F P O’Malley, Dushanthi Pinnaduwage, Timothy J. Whelan and Mark N. Levine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Anita Bane

40 papers receiving 1.2k citations

Peers

Countries citing papers authored by Anita Bane

Since Specialization

Citations

This map shows the geographic impact of Anita Bane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Bane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Bane more than expected).

Fields of papers citing papers by Anita Bane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Bane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Bane. The network helps show where Anita Bane may publish in the future.

Co-authorship network of co-authors of Anita Bane

This figure shows the co-authorship network connecting the top 25 collaborators of Anita Bane. A scholar is included among the top collaborators of Anita Bane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita Bane. Anita Bane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Canadian Recommendations on Optimal Breast Biopsy Practices Developed Using a Modified Delphi Panel 2025 ·Canadian Association of Radiologists Journal ·(unknown), Afsaneh Alikhassi, Anita Bane, (unknown), Erin Cordeiro, (unknown), J. M. Jessup, (unknown), Gary Ko, Zuzana Kos, (unknown), (unknown), (unknown), Elaine McKevitt, (unknown), (unknown), Caitlin Ward	1
2	Prognostic and predictive capacity of tumor infiltrating lymphocytes in the MA.20 regional node radiotherapy trial 2025 ·npj Breast Cancer ·Nazia Riaz, Bingshu E. Chen, Anita Bane, Dongxia Gao, Elisabeth Specht Stovgaard, Zuzana Kos, (unknown), (unknown), Wendy R. Parulekar, S. Chambers, Torsten O. Nielsen, Timothy J. Whelan	0
3	The Significance of Thyroid Hormone Receptors in Breast Cancer: A Hypothesis-Generating Narrative Review 2024 ·Current Oncology ·(unknown), (unknown), Sukhbinder Dhesy‐Thind, Anita Bane, Hon S. Leong, (unknown), (unknown), (unknown), Katarzyna J. Jerzak	3
4	Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial 2023 ·Histopathology ·Torsten O. Nielsen, Samuel Leung, Nazia Riaz, Anna Marie Mulligan, Zuzana Kos, Anita Bane, Timothy J. Whelan	3
5	Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force 2023 ·Current Oncology ·Hala Faragalla, Anna Plotkin, Penny J. Barnes, Fang‐I Lu, Zuzana Kos, Anna Marie Mulligan, Anita Bane, (unknown)	6
6	Abstract P6-04-02: Ki67 Assessment Protocol: Companion Diagnostic Biomarker for LUMINA Prospective Cohort Study 2023 ·Cancer Research ·(unknown), Samuel Leung, Nazia Riaz, Zuzana Kos, Anita Bane, Timothy J. Whelan	1
7	Downregulation of CYB5D2 is associated with breast cancer progression 2019 ·Scientific Reports ·Diane Ojo, David Rodríguez, Fengxiang Wei, Anita Bane, Damu Tang	11
8	The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism 2018 ·Scientific Reports ·Mitchell J. Elliott, Katarzyna J. Jerzak, (unknown), Zhaleh Safikhani, William D. Gwynne, John A. Hassell, Anita Bane, Jennifer Silvester, Kelsie L. Thu, Benjamin Haibe‐Kains, Tak W. Mak, David W. Cescon	10
9	Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer 2018 ·Cancer Letters ·Diane Ojo, Xiaozeng Lin, Ying Wu, (unknown), Anita Bane, Damu Tang	22
10	Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study 2018 ·Breast Cancer Research and Treatment ·Katarzyna J. Jerzak, (unknown), Sukhbinder Dhesy‐Thind, Gregory R. Pond, Kathleen I. Pritchard, Sharon Nofech‐Mozes, Peng Sun, Steven A. Narod, Anita Bane	15
11	Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours 2017 ·Breast Cancer Research ·Mira M. Shenouda, Amy Gillgrass, Tina Nham, Richard T. Hogg, Amanda J. Lee, Marianne V. Chew, (unknown), (unknown), Dean A. Lee, John A. Hassell, Anita Bane, Sukhbinder Dhesy‐Thind, Ali A. Ashkar	58
12	Claudin-Low Breast Cancer; Clinical & Pathological Characteristics 2017 ·PLoS ONE ·(unknown), Anna Dvorkin‐Gheva, Robin Hallett, Ying Wu, John A. Hassell, Gregory R. Pond, Mark N. Levine, Timothy J. Whelan, Anita Bane	120
13	A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer 2017 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Diane Ojo, Ying Wu, Anita Bane, Damu Tang	10
14	Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion 2015 ·Current Medicinal Chemistry ·Diane Ojo, (unknown), Yun Liu, Enli Wang, (unknown), Xiaozeng Lin, Nicholas Wong, Anita Bane, Damu Tang	56
15	Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications 2014 ·Breast Cancer Research and Treatment ·Katarzyna J. Jerzak, (unknown), Gregory R. Pond, Kathleen I. Pritchard, Steven A. Narod, Sukhbinder Dhesy‐Thind, Anita Bane	34
16	EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry 2011 ·Breast Cancer Research and Treatment ·Anita Bane, Anna Marie Mulligan, Dushanthi Pinnaduwage, Frances P. O’Malley, Irene L. Andrulis	7
17	Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer 2009 ·Nature Reviews Clinical Oncology ·Seema Panchal, (unknown), Frances P. O’Malley, Pavel Crystal, Jaime Escallón, Juanita Crook, Anita Bane, Louise Bordeleau	5
18	Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors 2008 ·Breast Cancer Research and Treatment ·Anita Bane, Dushanthi Pinnaduwage, (unknown), Shelley B. Bull, Frances P. O’Malley, Irene L. Andrulis	49
19	Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study 2005 ·Modern Pathology ·Teri A. Longacre, Marguerite Ennis, Louise Quenneville, Anita Bane, Ira J. Bleiweiss, Beverley A. Carter, (unknown), Michael Hendrickson, Hanina Hibshoosh, Lester J. Layfield, Lorenzo Memeo, Hong Wu, Frances P. O’Malley	84
20	Invasive lobular carcinoma: to grade or not to grade 2004 ·Modern Pathology ·Anita Bane, (unknown), Robert Parkes, Irene L. Andrulis, Frances P. O’Malley	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact